ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
DoorDash Inc

DoorDash Inc (DASH)

187.76
0.54
(0.29%)
Closed April 25 4:00PM
187.76
0.00
( 0.00% )
Pre Market: 4:51AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
187.76
Bid
186.42
Ask
188.48
Volume
142
0.00 Day's Range 0.00
99.32 52 Week Range 214.53
Market Cap
Previous Close
187.76
Open
-
Last Trade
32
@
188.09
Last Trade Time
04:02:37
Financial Volume
-
VWAP
-
Average Volume (3m)
6,388,911
Shares Outstanding
420,096,084
Dividend Yield
-
PE Ratio
641.26
Earnings Per Share (EPS)
0.29
Revenue
10.72B
Net Profit
123M

About DoorDash Inc

At DoorDash our mission to empower local economies shapes how our team members move quickly and always learn and reiterate to support merchants Dashers and the communities we serve. We are a technology and logistics company that started with door-to-door delivery and we are looking for team members ... At DoorDash our mission to empower local economies shapes how our team members move quickly and always learn and reiterate to support merchants Dashers and the communities we serve. We are a technology and logistics company that started with door-to-door delivery and we are looking for team members who can help us go from a company that is known for delivering food to a company that people turn to for any and all goods. DoorDash is growing rapidly and changing constantly which gives our team members the opportunity to share their unique perspectives solve new challenges and own their careers. Our leaders seek the truth and welcome big hairy audacious questions. Show more

Sector
Business Services, Nec
Industry
Business Services, Nec
Headquarters
Wilmington, Delaware, USA
Founded
-
DoorDash Inc is listed in the Business Services sector of the NASDAQ with ticker DASH. The last closing price for DoorDash was $187.76. Over the last year, DoorDash shares have traded in a share price range of $ 99.32 to $ 214.53.

DoorDash currently has 420,096,084 shares outstanding. The market capitalization of DoorDash is $78.88 billion. DoorDash has a price to earnings ratio (PE ratio) of 641.26.

DoorDash (DASH) Options Flow Summary

Overall Flow

Bullish

Net Premium

345k

Calls / Puts

166.67%

Buys / Sells

77.78%

OTM / ITM

88.24%

Sweeps Ratio

0.00%

DASH Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
19.535.34702350895178.23191.1168.953523427181.28295895CS
49.755.47722038088178.01192.69155.44586884178.23575532CS
121.60.859475719811186.16214.53155.46388911188.69379421CS
2632.821.1667527104154.96214.53152.26014514226183.12213099CS
5256.0742.5772647885131.69214.5399.324203795153.48084914CS
156112.82150.5471043574.94214.5369.94133265136.17851934CS
260112.82150.5471043574.94214.5369.94133265136.17851934CS

DASH - Frequently Asked Questions (FAQ)

What is the current DoorDash share price?
The current share price of DoorDash is $ 187.76
How many DoorDash shares are in issue?
DoorDash has 420,096,084 shares in issue
What is the market cap of DoorDash?
The market capitalisation of DoorDash is USD 78.88B
What is the 1 year trading range for DoorDash share price?
DoorDash has traded in the range of $ 99.32 to $ 214.53 during the past year
What is the PE ratio of DoorDash?
The price to earnings ratio of DoorDash is 641.26
What is the cash to sales ratio of DoorDash?
The cash to sales ratio of DoorDash is 7.36
What is the reporting currency for DoorDash?
DoorDash reports financial results in USD
What is the latest annual turnover for DoorDash?
The latest annual turnover of DoorDash is USD 10.72B
What is the latest annual profit for DoorDash?
The latest annual profit of DoorDash is USD 123M
What is the registered address of DoorDash?
The registered address for DoorDash is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the DoorDash website address?
The website address for DoorDash is www.doordash.com
Which industry sector does DoorDash operate in?
DoorDash operates in the BUSINESS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LGHLWLion Group Holding Ltd
$ 0.01
(66.67%)
5
RAASMI 3Fourteen REAL Asset Allocation ETF
$ 37.53
(56.02%)
229
ASRVAmeriServ Financial Inc
$ 3.74
(54.55%)
2
DSGNDesign Therapeutics Inc
$ 5.99
(54.38%)
4
MGTXMeiraGTx Holdings PLC
$ 9.99
(49.10%)
6
TOIIWOncology Institute Inc
$ 0.0055
(-94.58%)
180
MLACMountain Lake Acquisition Corporation
$ 5.01
(-50.40%)
1
CGNTCognyte Software Ltd
$ 5.01
(-48.35%)
5
SPRBSpruce Biosciences Inc
$ 0.0791
(-39.06%)
322.73k
LCNBLCNB Corporation
$ 9.01
(-36.46%)
6
AGMHAGM Group Holdings Inc
$ 0.07
(44.03%)
40.3M
WWWW International Inc
$ 0.437
(10.47%)
10.61M
GNLNGreenlane Holdings Inc
$ 0.0122
(-1.61%)
9.66M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 10.905
(4.35%)
8.81M
DMNDamon Inc
$ 0.0036
(2.86%)
5.47M

Discussion

View Full Feed
Methinks Methinks 4 minutes ago
https://www.japantimes.co.jp/news/2025/04/28/world/politics/us-aid-ukraine-russian-hacks/
I know one way to make this much cheaper! Use Wave.
Methinks Methinks 6 minutes ago
https://www.theregister.com/2025/04/28/who_me/
Are they joking about this now? Use Wave.
Just the facts maam Just the facts maam 8 minutes ago
Thanks Silvr. Since CGON has dragged their feet or contested discovery on many issues, it looks like they may be trying to delay the trial by extending deadlines.
ANIP
againstallodds againstallodds 10 minutes ago
You played loto, you lost, your fault

Stop whining

https://investorshub.advfn.com/uimage/uploads/2019/9/30/azehuMouse_GNCP.jpg
GNCP
jeunke22 jeunke22 18 minutes ago
Electromountain, Not difficult to understand at all. Many of us are all experiencing the same fate. You are not alone here. But it’s no use constantly looking backwards all the time. Get over it, “your paper losses’ could disappear faster than they happened. Try to look forward, Your probably stil
LWLG
MarauderEnchanter38 MarauderEnchanter38 31 minutes ago
Ich auch
TGLO
getmenews getmenews 36 minutes ago
Might be worth buying if they would stop diluting it!
XRPUSD
diggitydoodle diggitydoodle 39 minutes ago
Everyone still waiting for anything from the great CEO.
The new angle from the pumpers...wait until the new May fins for FOXO. As if any of the info from FOXO has done anything positive for this ticker. But hey, pumper posts have the little Santa emogis. That proves something. 🤣ǹ
FOXO RNVA
getmenews getmenews 40 minutes ago
Imagine your BTC being traced back to hackers, you don't think it won't be confiscated?

WAKE UP!
BTCUSD
Investor2014 Investor2014 50 minutes ago
I still think it would be worthwhile for biotech investors to do themselves to better understand the facts that do exist, instead of relying on raw ChatGPT nonsense..
AVXL
BIOCHEMUP BIOCHEMUP 52 minutes ago
I'm in. 
OMEX
Almosthere Almosthere 1 hour ago
We all know how it works. The 0.04 cent propagandists sell there shares into a lqmt pop, and then try to convince all the newbies to sell there shares.

They call this the wash rinse and repeat when it’s just really deception, manipulation, and preying on inexperienced investors.
LQMT
DewDiligence DewDiligence 1 hour ago
Recent Biotech Buyouts of Publicly Traded Companies

[Added MRK.DE-SWTX.]

Table entries are in descending order of buyout premium.
Reverse-mergers are listed at the bottom. [pre]
Acquired ‡Premium *Deal iHub
Company Buyer to Mark
ABT ABUS ACET
DewDiligence DewDiligence 1 hour ago
MRK.DE acquires SWTX for $47/sh cash—a 17% premium to SWTX’s “unaffected” share price on 2/7/25:

https://www.businesswire.com/news/home/20250427077657/en/Merck-KGaA-Darmstadt-Germany-to-Acquire-US-Biopharma-Company-SpringWorks-Therapeutics-to-Accelerate-Sustainable-Growth-of-Healthcar
MRK
Nemesis18 Nemesis18 1 hour ago
Unfortunately for you, your desire to get extremely wealthy off the back of this faux 'cancer treatment' is zero, as both the FDA & MHRA, are fully aware of this biotech's 20+ year criminally fraudulent, enterprise.

It's only morally corrupt parasites like you who think that they can
NWBO
ElectricMountain53 ElectricMountain53 1 hour ago
People are becoming disgruntled and angry because the former CEO of LWLG allegedly misled shareholders for years. This deception may have caused significant financial losses, as investors trusted the CEO's statements and strategies, only to discover that the company's performance or prospects were n
LWLG
PC retired PC retired 2 hours ago
"Unholy mixing of QREE and FLCX" ?, I would call it incestuous.
FLCX QREE
sam1933 sam1933 2 hours ago
🤔🫣w/$0.0001 AVERAGE COST (translate profit in writing) three hundred billion 💰️???
HBARUSD
getmenews getmenews 2 hours ago
yes
shajandr shajandr 2 hours ago
That's nott thinking, that's hallucinating.

https://investorshub.advfn.com/uimage/uploads/2024/1/31/unbbpdelusion_kob[mdelusions-quotes-3.jpg
https://investorshub.advfn.com/uimage/uploads/2024/2/17/mqvyidelusions_77.jpg
https://investorshub.advfn.com/uimage/uploads/2025
BCAP
eagle8 eagle8 2 hours ago
d_stock
@d_stock07734
·
5h
According to the PR from last December, YA II PN, Ltd. can convert all the Note into shares once sp is above $0.315 and after all the Note was converted, $NWBO can let YA II PN, Ltd load shares up to $50m. Is my understanding right? Can some $NW
NWBO
jimmy667 jimmy667 2 hours ago
I agree Gary. But remember the NWBO vs the Seven Market Makers lawsuit was instigated by NWBO and as a basis for liability alleged harm by illegal actions. This is a civil suit that alleged criminal actions. NWBO can collect damages that is all. But all evedence collected, deposition testimony elici
NWBO
pgsd pgsd 2 hours ago
Cell and Gene Therapy Sector Enters ‘Critical’ Period After Marks’ FDA Exit :
April 28, 2025

"This could be good news for the cell and gene therapy (CGT) space as many of these therapies—particularly those for rare indications—rely on surrogate endpoints that make them uniquely
CDMO

Your Recent History

Delayed Upgrade Clock